Archives
-
Ziprasidone Targets GOT1 in Pancreatic Cancer
2026-08-23
A 2022 Journal of Molecular Medicine study identifies ziprasidone as a non-competitive inhibitor of GOT1, an enzyme that supports glutamine-derived redox metabolism in pancreatic ductal adenocarcinoma. By combining enzyme, metabolic, cellular, genetic, and xenograft experiments, the authors connect GOT1 inhibition with impaired proliferation, migration, redox imbalance, and tumor growth.
-
AMPK, Mitophagy, and Periodontal Inflammation
2026-08-22
A 2026 FASEB Journal study identifies AMPK as an upstream coordinator linking PINK1/Parkin-mediated mitophagy with NLRP3-driven inflammation in mechanically loaded diabetic periodontal tissue. Its in vivo and in vitro design suggests that restoring mitochondrial turnover may help explain how periodontal ligament fibroblasts respond to the combined stresses of mechanical force and high glucose.
-
Isorhamnetin and PI3K/Akt Control of Oocyte Maturation
2026-08-22
The reference study shows that Isorhamnetin improves porcine oocyte maturation while reducing oxidative stress, apoptosis-associated changes, mitochondrial dysregulation, and endoplasmic reticulum stress. Its main innovation is the connection of these protective effects with PI3K/Akt pathway activation, providing a mechanistic framework for studying oocyte quality during in vitro maturation.
-
Hypoxia, Choroid Plexus, and Cognitive Impairment
2026-08-21
This mouse study identifies choroid plexus barrier failure as a mechanistic bridge between simulated high-altitude hypoxia and cognitive dysfunction. Its proposed cascade links abnormal AMPK signaling and oxidative stress with M1 macrophage polarization, offering a focused framework for investigating neuroimmune responses to hypoxic stress.
-
Celastrol, CAV-1, and Mitophagy in Liver Cancer
2026-08-20
A 2026 Phytomedicine study identifies mitochondrial cholesterol overload as a previously underdefined link between celastrol exposure, mitophagy, and liver cancer suppression. By combining cholesterol localization assays, transcriptomics, protein-interaction studies, and xenograft validation, the work positions the CAV-1/SCP2 axis as a mechanistic regulator of organelle-specific lipid stress.
-
Selonsertib (GS-4997) in ASK1 Stress Signaling
2026-08-20
Selonsertib (GS-4997) provides a selective way to test whether ASK1-driven oxidative-stress signaling contributes to inflammation, fibrosis, and metabolic injury. This workflow connects pathway inhibition with the Galectin-1–FIP200 autophagy findings while clearly separating established evidence from exploratory liver-disease applications.
-
Angiotensin 1/2 (5-7): Assay Interpretation Guide
2026-08-19
Angiotensin 1/2 (5-7) is a compact H2N-Ile-His-Pro-OH peptide for studying fragment-specific renin-angiotensin biology. This guide explains how to interpret cardiovascular and spike-receptor binding data without confusing biochemical activity with clinical or infectious-disease causation.
-
MLN2238: Designing Causal Proteostasis Assays
2026-08-19
MLN2238 is a potent proteasome β5 subunit inhibitor for dissecting proteotoxic stress, apoptosis, and adaptive signaling. This guide translates ROS–JNK–CREB findings into more informative assay designs for oncology and proteostasis research.
-
Dextromethorphan hydrobromide Research Workflows
2026-08-18
Build reproducible excitotoxicity, calcium-signaling, and ischemia workflows with a research-grade NMDA receptor antagonist. This guide pairs practical handling advice with orthogonal assay design, helping distinguish receptor-mediated neuroprotection from nonspecific ion-channel or vehicle effects.
-
Minoxidil Sulphate: From Probe to Assay Logic
2026-08-18
Minoxidil sulphate is more than a potassium-channel research reagent: it can help separate molecular vasodilation from organ-level vascular dysfunction. This evidence-led guide connects renal perfusion experiments with hair follicle and vascular biology research while defining practical limits for interpretation.
-
CUDC-907 Protocol and QC Guide
2026-08-17
CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone acetylation, cell-cycle progression, and apoptosis. This guide uses product-dossier information and workflow recommendations rather than directly matched paper evidence; the compound is for research use only and not for diagnostic, therapeutic, or clinical applications.
-
Perphenazine Workflows for D2 Receptor Research
2026-08-17
Perphenazine is a dopamine D2 receptor antagonist that connects receptor pharmacology with mitochondrial toxicity and host-directed antibacterial assays. This practical guide covers compound preparation, ROS and autophagy measurements, macrophage workflows, controls, and troubleshooting for reproducible research.
-
Aztreonam in Gram-Negative Research Workflows
2026-08-16
Aztreonam offers a defined monocyclic β-lactam framework for Gram-negative susceptibility testing, resistance analysis, and mechanistic cell studies. This workflow-focused guide connects antimicrobial assays with bone marrow and hepatic microsome models while emphasizing solvent control, storage, and interpretation limits.
-
Oxaliplatin: From DNA Damage to Translational Strategy
2026-08-15
Oxaliplatin is more than a cytotoxicity benchmark: it is a mechanistic probe for studying DNA damage, apoptosis, metastatic heterogeneity, and treatment resistance. This translational guide connects its DNA adduct biology with patient-derived models and strategic experimental design.
-
2,7-Dichlorodihydrofluorescein diacetate Guide
2026-08-14
2,7-Dichlorodihydrofluorescein diacetate, also called DCFH-DA, is a cell-permeable fluorogenic reagent for relative intracellular oxidant measurements. Its fluorescence supports microscopy, flow cytometry, and plate assays, but the signal is not specific for one ROS or equivalent to direct DNA-break measurement.